Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 917081-58-4 | MDL No. : | MFCD30180247 |
Formula : | C15H22N2O6 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | MBNPMTPOCIYNPX-UHFFFAOYSA-N |
M.W : | 326.35 | Pubchem ID : | 11993949 |
Synonyms : |
|
Num. heavy atoms : | 23 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.6 |
Num. rotatable bonds : | 6 |
Num. H-bond acceptors : | 6.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 84.33 |
TPSA : | 96.6 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.8 cm/s |
Log Po/w (iLOGP) : | 2.39 |
Log Po/w (XLOGP3) : | 2.1 |
Log Po/w (WLOGP) : | 1.88 |
Log Po/w (MLOGP) : | 1.02 |
Log Po/w (SILICOS-IT) : | 1.02 |
Consensus Log Po/w : | 1.68 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.98 |
Solubility : | 0.339 mg/ml ; 0.00104 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.76 |
Solubility : | 0.0568 mg/ml ; 0.000174 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -1.98 |
Solubility : | 3.43 mg/ml ; 0.0105 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 3.11 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 122567-97-9 ]
((2S,5R)-5-(5-Methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2,5-dihydrofuran-2-yl)methyl benzoate
Similarity: 0.69
[ 4401-71-2 ]
1,3,5-Trimethylpyrimidine-2,4(1H,3H)-dione
Similarity: 0.68
[ 157327-41-8 ]
1-Boc-3-[(Dimethylamino)methylene]-4-oxopiperidine
Similarity: 0.67
[ 4869-46-9 ]
1,3-Dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carbaldehyde
Similarity: 0.67
[ 20924-05-4 ]
2-(5-Methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetic acid
Similarity: 0.66
[ 122567-97-9 ]
((2S,5R)-5-(5-Methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2,5-dihydrofuran-2-yl)methyl benzoate
Similarity: 0.69
[ 4401-71-2 ]
1,3,5-Trimethylpyrimidine-2,4(1H,3H)-dione
Similarity: 0.68
[ 4869-46-9 ]
1,3-Dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carbaldehyde
Similarity: 0.67
[ 20924-05-4 ]
2-(5-Methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetic acid
Similarity: 0.66
[ 23956-12-9 ]
5-(2-Hydroxyethyl)pyrimidine-2,4(1H,3H)-dione
Similarity: 0.64